Pancreatic cancer
Pancreatic carcinoma is a common pancreatic tumor. It is a highly malignant digestive tract tumor that is difficult to diagnose and treat. About 90% of pancreatic cancers are ductal adenocarcinomas that originate from the glandular duct epithelium. Its morbidity and mortality rates have increased significantly in recent years. The 5-year survival rate is less than 1%, making it one of the malignant tumors with the worst prognosis. The early diagnosis rate of pancreatic cancer is not high, the surgical mortality rate is high, and the cure rate is very low. The incidence of this disease is higher in men than in women, with a male-to-female ratio of 1.5 to 2:1. Male patients are much more common than premenopausal women, and the incidence rate of postmenopausal women is similar to that of men.
-
Site of disease:
pancreas -
Infectious :
Not contagious -
Frequent population:
Adult women and breastfeeding women are more likely to get -
Related symptoms:
Upper abdominal pain Upper abdominal mass and bloating Transverse colon displacement Fatigue Weight loss
Related Drugs
Gemcitabine Hydrochloride for Injection
Indication: Non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
Manufacturer:
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Fluorouracil Sodium Chloride Injection
Indication: 1. Used as adjuvant chemotherapy and palliative treatment for breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system cancer and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma. 2. Main chemotherapy drug for the treatment of malignant hydatidiform mole and choriocarcinoma. 3. Head and neck malignancies and liver cancer.
Manufacturer:
Qingzhou Yaowang Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Qilu Pharmaceutical (Hainan) Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Shenyang Yaoda Leiyunshang Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Docetaxel
Indication: It is mainly used to treat advanced breast cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, and small cell lung cancer; it also has certain effects on gastric cancer, pancreatic cancer, melanoma, etc.
Manufacturer:
Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.
LYNPARZA- olaparib_tablet, film coated
Indication: Lynparza is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated: Ovarian cancer BRCA 1. 1 BRCA 1. 1 Breast cancer BRCA 1. 1 gBRCA 1. 1 Pancreatic cancer gBRCA 1. 1 Prostate cancer 1. 1 BRCA BRCA 1. 1 Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA [see Dosage and Administration (2. 1) ] Lynparza is indicated in combination with bevacizumab for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD)-positive status defined by either: BRCA Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza [see Dosage and Administration (2. 1) Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA [see Error! Hyperlink reference not valid. ] Lynparza is indicated for the adjuvant treatment of adult patients with deleterious or suspected deleterious gBRCA [ Dosage and Administration (2. 1) Lynparza is indicated for the treatment of adult patients with deleterious or suspected deleterious gBRCA [see Dosage and Administration (2. 1) Lynparza is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious gBRCA [see Dosage and Administration (2. 1) Lynparza is indicated for the treatment of adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with enzalutamide or abiraterone. Select patients for therapy based on an FDA-approved companion diagnostic for Lynparza [see Dosage and Administration (2. 1) Lynparza is indicated in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with deleterious or suspected deleterious BRCA BRCAm [see Error! Hyperlink reference not valid.
Manufacturer:
AstraZeneca Pharmaceuticals LP
CAPECITABINE- capecitabine_tablet, film coated
Indication: Capecitabine is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer 1. 1 Breast Cancer 1. 2 Gastric, Esophageal, or Gastroesophageal Junction Cancer 1. 3 Pancreatic Cancer 1. 4 Capecitabine tablet is indicated for the: Capecitabine tablet is indicated for the: Capecitabine tablet is indicated for the: Capecitabine tablet is indicated for the adjuvant treatment of adults with pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.
Manufacturer:
BluePoint Laboratories